Pfizer stock diagnosed with positive potential
Following a tough few years and trading near multi-year lows, independent analyst Alistair Strang gives the pharma giant's stock a health check.
21st May 2025 07:41
by Alistair Strang from Trends and Targets
Choosing to investigate Pfizer Inc (NYSE:PFE) became obvious due to my rolling my sleeve up at 10.33am and received the utterly painless jab. It looks like I’ve had nine vaccinations, only one from AstraZeneca back in the older days, all eight others served up by Pfizer. The nurse asked if I wanted to go through the potential side effects; it was easy to shrug and leave as I’ve never experienced any grief from Pfizer. Until now…
- Invest with ii: Open a Stocks & Shares ISA | Top ISA Funds | Transfer your ISA to ii
Sitting working on this report, I’m being forced to stop every now and then and huddle over an electric heater. Literally every part of my body bursts into unexpected shakes, making typing quite an adventure. It’s safe to suggest I’m experiencing my very first Covid-19 vaccination side effects.
Source: Trends and Targets. Past performance is not a guide to future performance.
It’s now the case where above $25 calculates with the potential of a lift to an initial $31 with our longer-term secondary, if beaten, at $38. For the longer-term, we can calculate a distant $41 as exerting an attraction.
Our alternate scenario allow below $22.5 to provoke reversal to an initial $21 with our secondary, if broken, an eventual bottom around $18.
Alistair Strang has led high-profile and "top secret" software projects since the late 1970s and won the original John Logie Baird Award for inventors and innovators. After the financial crash, he wanted to know "how it worked" with a view to mimicking existing trading formulas and predicting what was coming next. His results speak for themselves as he continually refines the methodology.
Alistair Strang is a freelance contributor and not a direct employee of Interactive Investor. All correspondence is with Alistair Strang, who for these purposes is deemed a third-party supplier. Buying, selling and investing in shares is not without risk. Market and company movement will affect your performance and you may get back less than you invest. Neither Alistair Strang or Interactive Investor will be responsible for any losses that may be incurred as a result of following a trading idea.
These articles are provided for information purposes only. Occasionally, an opinion about whether to buy or sell a specific investment may be provided by third parties. The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.
Full performance can be found on the company or index summary page on the interactive investor website. Simply click on the company's or index name highlighted in the article.